MedPath

A Study on the Effects of Mastiha Oil in Adults With Hypertriglyceridemia

Not Applicable
Not yet recruiting
Conditions
Hypertriglyceridemia
Interventions
Dietary Supplement: MastihaOil
Behavioral: nutritional counsel
Registration Number
NCT06323252
Lead Sponsor
Harokopio University
Brief Summary

Mastiha Oil is a 100% natural product of the Mediterranean, extracted from the resin of Mastiha. Its composition is high in bioactive ingredients (such as terpenic acids and polyphenols) which have proven anti-inflammatory, antioxidant, cardioprotective, chemoprotective and antimicrobial properties. The aim of this study is to determine the effect of Mastiha oil in adults with Hypetriglyceridemia. 100 participants will be allocated to two groups, (50 in intervention group and 50 in control group). Mastiha oil will be provided in the form of soft gel capsules to the intervention group, whereas the control group will not consume the capsules. Both groups will receive standard nutritional counselling. The intervention will last 3 months.

The effects of the intervention will be evaluated via clinical and laboratory markers.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • 30 years < Age < 75 years Hypetriglyceridemia A stable weight for ≥ 3 months pre-intervention An unchanged treatment regimen for ≥ 6 months pre-intervention
Exclusion Criteria

Hepatotoxic Medication Untreated Diabetes Mellitus Dysthyroidism, hypopituitarism, Cushing syndrome / disease Pregnancy, lactation Psychiatric or mental disorder Any use of antioxidant-phytochemical rich supplement, vitamin D supplement, anti-, pre- or pro-biotics within 3 months pre-intervention

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupMastihaOilParticipants with hypetriglyceridemia will be subjected to nutritional counsel and the intake of 1 soft gel capsule daily for a total of 3 months.
Control groupnutritional counselParticipants with hypetriglyceridemia will be subjected to nutritional counsel for a total of 3 months.
Primary Outcome Measures
NameTimeMethod
Change in blood triglycerides3 months

Levels will be evaluated pre and prost intervention in both control and intervention groups

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath